Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
- PMID: 35836668
- PMCID: PMC9276173
- DOI: 10.1097/TXD.0000000000001191
Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
Erratum in
-
Erratum: Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension: Erratum.Transplant Direct. 2023 Jan 19;9(2):e1444. doi: 10.1097/TXD.0000000000001444. eCollection 2023 Feb. Transplant Direct. 2023. PMID: 36700063 Free PMC article.
Abstract
Kidney transplantation (KT) is controversial in patients with pretransplant pulmonary hypertension (PtPH). We aimed to quantify post-KT graft and patient survival as well as survival benefit in recipients with PtPH.
Methods: Using UR Renal Data System (2000-2018), we studied 90 819 adult KT recipients. Delayed graft function, death-censored graft failure, and mortality were compared between recipients with and without PtPH using inverse probability weighted logistic and Cox regression. Survival benefit of KT was determined using stochastic matching and stabilized inverse probability treatment Cox regression.
Results: Among 90 819 KT recipients, 2641 (2.9%) had PtPH. PtPH was associated with higher risk of delayed graft function (odds ratio, 1.23; 95% CI, 1.10-1.36; P < 0.01), death-censored graft failure (hazard ratio [HR], 1.23; 95% CI, 1.11-1.38; P < 0.01), and mortality (HR, 1.56; 95% CI, 1.44-1.69; P < 0.01). However, patients with PtPH who received a KT had a 46% reduction in mortality (HR, 0.54; 95% CI, 0.48-0.61; P < 0.01) compared with those who remained on the waitlist.
Conclusions: Although PtPH is associated with inferior post-KT outcomes, KT is associated with better survival compared with remaining on the waitlist. Therefore, KT is a viable treatment modality for appropriately selected patients with PtPH.
Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Issa N, Krowka MJ, Griffin MD, et al. . Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008;86:1384–1388. - PubMed
-
- Stallworthy EJ, Pilmore HL, Webster MW, et al. . Do echocardiographic parameters predict mortality in patients with end-stage renal disease? Transplantation. 2013;95:1225–1232. - PubMed
-
- Zlotnick DM, Axelrod DA, Chobanian MC, et al. . Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transplant. 2010;25:3090–3096. - PubMed
-
- Casas-Aparicio G, Castillo-Martínez L, Orea-Tejeda A, et al. . The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension. Transplant Proc. 2010;42:3524–3528. - PubMed
-
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
